[Successful treatment with immunosuppressive therapy for aplastic anemia developed after resection of thymoma].

Eriko Sada, Motoaki Shiratsuchi, Hirofumi Ohno, Eriko Nagasawa, Emi Honda, Ryoichi Takayanagi, Yasunobu Abe

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

We report here a very severe case of thymoma-related aplastic anemia that developed after thymectomy. The patient was a 50-year-old man diagnosed with myasthenia gravis. Chest CT showed thymoma measuring 7.5 cm in diameter, and extended thymectomy was performed. Irradiation to the anterior mediastinum was added postoperatively. Thirteen months after surgery, hemogram showed severe neutropenia: leukocyte count 0.32×10(9)/l with 11% neutrophils; Hb 10.7 g/dl; and platelet count 100×10(9)/l. Although cyclosporine (CSP, 5 mg/kg/day) was administered, dose reduction was necessary because of renal damage. Cytopenia deteriorated to a leukocyte count of 0.71×10(9)/l with 21% neutrophils; Hb 5.9 g/dl; and platelet count 24×10(9)/l. However, addition of antithymocyte globulin (ATG, 15 mg/kg) led to hematopoietic recovery of all three lineages within one month. He is clinically stable with no transfusion requirement after 22 months with CSP maintenance therapy. Although thymoma-related aplastic anemia has been reported to have an extremely poor prognosis, high efficacy of CSP has been reported recently. In our case, ATG in combination with CSP was efficient. Adequate immunosuppressive therapy seems to be important for the clinical management of these patients.

Original languageEnglish
Pages (from-to)293-298
Number of pages6
Journal[Rinshō ketsueki] The Japanese journal of clinical hematology
Volume52
Issue number5
Publication statusPublished - May 1 2011

Fingerprint

Thymoma
Aplastic Anemia
Immunosuppressive Agents
Thymectomy
Platelet Count
Leukocyte Count
Neutrophils
Antilymphocyte Serum
Myasthenia Gravis
Mediastinum
Neutropenia
Cyclosporine
Thorax
Therapeutics
Kidney

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

[Successful treatment with immunosuppressive therapy for aplastic anemia developed after resection of thymoma]. / Sada, Eriko; Shiratsuchi, Motoaki; Ohno, Hirofumi; Nagasawa, Eriko; Honda, Emi; Takayanagi, Ryoichi; Abe, Yasunobu.

In: [Rinshō ketsueki] The Japanese journal of clinical hematology, Vol. 52, No. 5, 01.05.2011, p. 293-298.

Research output: Contribution to journalReview article

Sada, Eriko ; Shiratsuchi, Motoaki ; Ohno, Hirofumi ; Nagasawa, Eriko ; Honda, Emi ; Takayanagi, Ryoichi ; Abe, Yasunobu. / [Successful treatment with immunosuppressive therapy for aplastic anemia developed after resection of thymoma]. In: [Rinshō ketsueki] The Japanese journal of clinical hematology. 2011 ; Vol. 52, No. 5. pp. 293-298.
@article{558ba57cc5df40ba9b20a0641a12b622,
title = "[Successful treatment with immunosuppressive therapy for aplastic anemia developed after resection of thymoma].",
abstract = "We report here a very severe case of thymoma-related aplastic anemia that developed after thymectomy. The patient was a 50-year-old man diagnosed with myasthenia gravis. Chest CT showed thymoma measuring 7.5 cm in diameter, and extended thymectomy was performed. Irradiation to the anterior mediastinum was added postoperatively. Thirteen months after surgery, hemogram showed severe neutropenia: leukocyte count 0.32×10(9)/l with 11{\%} neutrophils; Hb 10.7 g/dl; and platelet count 100×10(9)/l. Although cyclosporine (CSP, 5 mg/kg/day) was administered, dose reduction was necessary because of renal damage. Cytopenia deteriorated to a leukocyte count of 0.71×10(9)/l with 21{\%} neutrophils; Hb 5.9 g/dl; and platelet count 24×10(9)/l. However, addition of antithymocyte globulin (ATG, 15 mg/kg) led to hematopoietic recovery of all three lineages within one month. He is clinically stable with no transfusion requirement after 22 months with CSP maintenance therapy. Although thymoma-related aplastic anemia has been reported to have an extremely poor prognosis, high efficacy of CSP has been reported recently. In our case, ATG in combination with CSP was efficient. Adequate immunosuppressive therapy seems to be important for the clinical management of these patients.",
author = "Eriko Sada and Motoaki Shiratsuchi and Hirofumi Ohno and Eriko Nagasawa and Emi Honda and Ryoichi Takayanagi and Yasunobu Abe",
year = "2011",
month = "5",
day = "1",
language = "English",
volume = "52",
pages = "293--298",
journal = "[Rinsho ketsueki] The Japanese journal of clinical hematology",
issn = "0485-1439",
publisher = "Nihon Rinsho Ketsueki Gakkai/Japan Society of Clinical Hematology",
number = "5",

}

TY - JOUR

T1 - [Successful treatment with immunosuppressive therapy for aplastic anemia developed after resection of thymoma].

AU - Sada, Eriko

AU - Shiratsuchi, Motoaki

AU - Ohno, Hirofumi

AU - Nagasawa, Eriko

AU - Honda, Emi

AU - Takayanagi, Ryoichi

AU - Abe, Yasunobu

PY - 2011/5/1

Y1 - 2011/5/1

N2 - We report here a very severe case of thymoma-related aplastic anemia that developed after thymectomy. The patient was a 50-year-old man diagnosed with myasthenia gravis. Chest CT showed thymoma measuring 7.5 cm in diameter, and extended thymectomy was performed. Irradiation to the anterior mediastinum was added postoperatively. Thirteen months after surgery, hemogram showed severe neutropenia: leukocyte count 0.32×10(9)/l with 11% neutrophils; Hb 10.7 g/dl; and platelet count 100×10(9)/l. Although cyclosporine (CSP, 5 mg/kg/day) was administered, dose reduction was necessary because of renal damage. Cytopenia deteriorated to a leukocyte count of 0.71×10(9)/l with 21% neutrophils; Hb 5.9 g/dl; and platelet count 24×10(9)/l. However, addition of antithymocyte globulin (ATG, 15 mg/kg) led to hematopoietic recovery of all three lineages within one month. He is clinically stable with no transfusion requirement after 22 months with CSP maintenance therapy. Although thymoma-related aplastic anemia has been reported to have an extremely poor prognosis, high efficacy of CSP has been reported recently. In our case, ATG in combination with CSP was efficient. Adequate immunosuppressive therapy seems to be important for the clinical management of these patients.

AB - We report here a very severe case of thymoma-related aplastic anemia that developed after thymectomy. The patient was a 50-year-old man diagnosed with myasthenia gravis. Chest CT showed thymoma measuring 7.5 cm in diameter, and extended thymectomy was performed. Irradiation to the anterior mediastinum was added postoperatively. Thirteen months after surgery, hemogram showed severe neutropenia: leukocyte count 0.32×10(9)/l with 11% neutrophils; Hb 10.7 g/dl; and platelet count 100×10(9)/l. Although cyclosporine (CSP, 5 mg/kg/day) was administered, dose reduction was necessary because of renal damage. Cytopenia deteriorated to a leukocyte count of 0.71×10(9)/l with 21% neutrophils; Hb 5.9 g/dl; and platelet count 24×10(9)/l. However, addition of antithymocyte globulin (ATG, 15 mg/kg) led to hematopoietic recovery of all three lineages within one month. He is clinically stable with no transfusion requirement after 22 months with CSP maintenance therapy. Although thymoma-related aplastic anemia has been reported to have an extremely poor prognosis, high efficacy of CSP has been reported recently. In our case, ATG in combination with CSP was efficient. Adequate immunosuppressive therapy seems to be important for the clinical management of these patients.

UR - http://www.scopus.com/inward/record.url?scp=80053628041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053628041&partnerID=8YFLogxK

M3 - Review article

C2 - 21646776

AN - SCOPUS:80053628041

VL - 52

SP - 293

EP - 298

JO - [Rinsho ketsueki] The Japanese journal of clinical hematology

JF - [Rinsho ketsueki] The Japanese journal of clinical hematology

SN - 0485-1439

IS - 5

ER -